Saturday 17 October 2026
Export PHAR’s income statement to Excel — free account
Pharming Group N.V. Sponsored ADR
PHAR Healthcare Biotechnology
Pharming Group N.V. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 26.6% from fiscal 2024. In the quarter to June 2026, revenue fell 3.22%, EPS fell 57.1%, free cash flow fell 183.9% and total debt rose 1.55%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
9.36
0.27
−2.80%
Follow PHAR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 5 | 5 | 7 |
+8 more TTM periods Free account |
| 3.67% | 5.10% | 1.14% | 0.12% | ||
| 2.05% | 2.77% | 0.63% | 0.06% | ||
ROIC |
5.50% | 8.88% | 8.27% | 8.36% | |
Return on Tangible Assets |
4.83% | 6.50% | 1.49% | 0.15% | |
Average Days of Receivables |
56.75 | 59.31 | 53.08 | 43.93 | |
Free Cash Flow per Share |
0.64 | 0.75 | 0.78 | 0.77 | |
Free Cash Flow |
34.37 | 55.72 | 53.95 | 52.71 | |
Capital Expenditures |
(0.66) | (0.70) | (0.75) | (0.62) | |
| Other line items | |||||
Cash ROIC |
6.53% | 10.35% | 9.72% | 9.95% | |
Accounts Receivable Turnover |
6.64 | 6.87 | 6.87 | 7.89 | |
Accounts Payable Turnover |
0.61 | 0.51 | 0.53 | 0.49 | |
Inventory Turnover |
0.76 | 0.71 | 0.75 | 0.57 | |
Average Days of Payables |
609.22 | 862.30 | 849.52 | 779.31 | |
Days of Inventory on Hand |
484.20 | 537.88 | 520.64 | 668.87 | |
Tax Rate |
(0.42) | (0.39) | (0.80) | (1.00) | |
Research and Development Expense of Revenue |
30.94% | 28.36% | 26.68% | 25.00% | |
Selling, General and Administrative Expense of Revenue |
52.23% | 53.98% | 56.08% | 58.31% | |
Share Based Compensation of Revenue |
3.90% | 3.90% | 3.66% | 3.28% | |
Operating CF/Net income |
3.74 | 4.57 | 19.19 | 185.18 | |
Depreciation/Fixed assets |
1.88 | 1.71 | 1.55 | 2.10 | |
Capex/Depreciation |
(0.05) | (0.06) | (0.07) | (0.04) | |
Revenue per Share |
6.87 | 4.96 | 5.46 | 5.31 | |
Operating CF per Share |
0.66 | 0.76 | 0.79 | 0.78 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates